IRIS
MEDAGLINI, DONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.159
EU - Europa 9.072
AS - Asia 5.273
SA - Sud America 918
AF - Africa 310
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 25.766
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.979
RU - Federazione Russa 2.010
SG - Singapore 1.703
CN - Cina 1.684
GB - Regno Unito 1.507
IT - Italia 1.299
IE - Irlanda 1.202
BR - Brasile 741
SE - Svezia 655
VN - Vietnam 586
DE - Germania 576
UA - Ucraina 527
FR - Francia 483
HK - Hong Kong 439
FI - Finlandia 412
KR - Corea 288
ZA - Sudafrica 182
IN - India 161
CA - Canada 102
ES - Italia 72
NL - Olanda 61
BD - Bangladesh 58
PL - Polonia 56
AR - Argentina 53
MX - Messico 44
IQ - Iraq 40
JP - Giappone 40
NG - Nigeria 40
TR - Turchia 39
UZ - Uzbekistan 37
AT - Austria 33
BE - Belgio 33
VE - Venezuela 27
PK - Pakistan 25
EC - Ecuador 23
ID - Indonesia 22
CH - Svizzera 19
CL - Cile 19
CZ - Repubblica Ceca 19
AU - Australia 18
LT - Lituania 18
CI - Costa d'Avorio 17
KE - Kenya 16
CO - Colombia 14
IR - Iran 14
SA - Arabia Saudita 14
EG - Egitto 13
MA - Marocco 13
MY - Malesia 13
GR - Grecia 11
PE - Perù 11
PH - Filippine 11
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
IL - Israele 10
BO - Bolivia 9
EU - Europa 9
JO - Giordania 9
NP - Nepal 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
PT - Portogallo 8
UY - Uruguay 8
AZ - Azerbaigian 7
ET - Etiopia 7
OM - Oman 7
SI - Slovenia 7
RS - Serbia 6
TH - Thailandia 6
BG - Bulgaria 5
MD - Moldavia 5
PA - Panama 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
CR - Costa Rica 4
DZ - Algeria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
LK - Sri Lanka 4
MT - Malta 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
EE - Estonia 3
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
JM - Giamaica 3
LV - Lettonia 3
PS - Palestinian Territory 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
GT - Guatemala 2
Totale 25.727
Salva come PNG Salva come JPEG
Città #
Dallas 1.402
Southend 1.208
Dublin 1.198
Singapore 936
Fairfield 889
Ashburn 832
Chandler 679
Moscow 541
Santa Clara 512
Jacksonville 420
Hong Kong 415
Woodbridge 400
Beijing 397
Siena 368
Hefei 335
Houston 330
Seattle 330
Wilmington 313
Cambridge 297
Seoul 280
San Jose 274
Ann Arbor 246
Helsinki 219
Los Angeles 199
Princeton 199
Munich 176
The Dalles 163
Johannesburg 162
New York 151
Milan 143
Ho Chi Minh City 137
Nanjing 135
Hanoi 132
Lauterbourg 130
Council Bluffs 124
Dong Ket 121
Florence 93
Rome 80
Lappeenranta 73
San Mateo 73
Boardman 69
São Paulo 68
San Diego 66
Shanghai 60
Buffalo 59
Lancaster 59
Orem 53
Shenyang 50
Menlo Park 48
London 46
Frankfurt am Main 44
Nanchang 42
Nuremberg 41
Turku 40
Redondo Beach 39
Bengaluru 38
Tokyo 38
Abuja 37
Chicago 35
Montreal 35
Chennai 33
Denver 32
Toronto 32
Brussels 31
Columbus 31
Dearborn 30
Tashkent 30
Warsaw 30
Amsterdam 29
Phoenix 28
Tianjin 28
Málaga 27
San Francisco 26
Düsseldorf 25
Kunming 25
Washington 25
Da Nang 23
Hebei 23
Jiaxing 23
Belo Horizonte 22
Guangzhou 22
Haiphong 22
Fremont 21
Brooklyn 20
Poplar 20
Rio de Janeiro 19
Abidjan 17
Atlanta 17
Norwalk 17
Changsha 16
Madrid 16
Stockholm 16
Messina 15
Mumbai 15
Redwood City 15
Zhengzhou 15
Baghdad 14
Dhaka 14
Jinan 14
Portsmouth 14
Totale 16.971
Salva come PNG Salva come JPEG
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 353
13C-NMR determination of simultaneous xylose and glucose fermentation by a newly isolated strain (G11) of Klebsiella planticola 337
Vaginal immunization to elicit primary T-cell activation and dissemination 327
A stochastic model for CD4+ T cell proliferation and dissemination network in primary immune response 312
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 310
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 302
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 298
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori 295
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 288
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice 284
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 282
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 281
Ebola vaccine R&D: Filling the knowledge gaps 279
Vaccination in the elderly: The challenge of immune changes with aging 277
Correlates of vaccine-induced protective immunity against Ebola virus disease 272
Adoptive transfer of transgenic T cells to study mucosal adjuvants 270
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 268
Role of the microbiota in the modulation of vaccine immune responses 260
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine 260
Identification of a branching process model for adaptive immune response 259
Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells 255
Interferon-γ from Brain Leukocytes Enhances Meningitis by Type 4 Streptococcus pneumoniae 253
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 250
Big science for vaccine development 250
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 241
Assessment of mucosal immunity to HIV-1 234
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 228
Modulation of Primary Immune Response by Different Vaccine Adjuvants 227
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 221
Biotechnological approaches to fight pathogens at mucosal sites 215
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 214
Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface 209
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 208
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 205
The European research effort for HIV/AIDS, malaria and tuberculosis 204
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 203
Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii 202
ADITEC: joining forces for next-generation vaccines 202
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva 202
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 201
Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii 200
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 199
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 197
Recombinant Gram-positive bacteria as vehicles of vaccine antigens 196
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts 194
Vaccine adjuvants: A priority for vaccine research 192
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 192
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 189
O:2-CRM(197) Conjugates against Salmonella Paratyphi A 189
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 188
La diagnosi eziologica della polmonite comunitaria: possibile ruolo della Real-Time PCR in una coorte di pazienti adulti e pediatrici 187
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 185
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 185
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 185
Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii 184
Spike-Specific memory B cell response in hematopoietic cell transplantation recipients following multiple mRNA-1273 vaccinations: a longitudinal observational study 182
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts 181
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 180
The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1 180
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 180
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 177
Physicochemical characterization cascade of nanoadjuvant–antigen systems for improving vaccines 177
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 175
Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis 175
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 174
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 174
Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols 173
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 173
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 173
Gram-positive commensal bacteria for mucosal vaccine delivery. 172
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 172
Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice 171
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 171
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 170
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 168
Primary T-cell response to mucosal vaccination 168
From bivariate to multivariate analysis of cytometric data: overview of computational methods and their application in vaccination studies 168
Innate immunity against HIV: a priority target for HIV prevention research 167
Immunogenicity of a bivalent adjuvanted glycoconjugate vaccine against Salmonella typhimurium and Salmonella Enteritidis 165
Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii 163
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 163
Surface display of recombinant proteins on Bacillus subtilis spores 162
In vivo mucosal delivery of bioactive human interleukin 1 recepor antagonist produced by Streptococcus gordonii 162
The European effort towards the development of mucosal vaccines for poverty-related diseases 161
Impact of interproximal composite restorations on periodontal tissue health: Clinical and cytokine profiles from a pre-post quasi-experimental study 160
Vaginal immunization with recombinant gram-positive bacteria 159
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 159
NMR Investigation of the Simultaneous Fermentation of Xylose and Glucose by a Selected Strain of Klebsiella Planticola (G11) 157
Ruolo del sierotipo capsulare nella suscettibilità di Streptococcus pneumoniae alla cellula microgliale 157
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination 157
Recombinant gram-positive bacteria for intranasal immunization: characterization of the murine nasal-associated lymphoid tissue and study of local T-cell priming 156
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 155
Recombinant Streptococcus gordonii as live vehicle for vaccine antigens. 155
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 153
Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens 152
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 152
Editorial: Advanced Immunization Technologies for Next Generation Vaccines 152
Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization 150
Expression of measles virus antigens in Streptococcus gordonii 148
Recombinant Streptococcus gordonii as a mucosal vaccine vector 147
Totale 20.546
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.949
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021637 0 0 0 0 0 0 0 0 0 253 175 209
2021/20221.596 117 226 98 159 64 27 85 53 84 143 184 356
2022/20232.363 147 238 319 306 213 466 61 206 182 49 119 57
2023/20242.030 73 67 160 118 79 518 668 65 43 87 35 117
2024/20254.399 129 179 429 249 536 278 204 265 435 180 424 1.091
2025/20269.163 780 1.462 1.040 1.218 1.842 356 1.045 383 473 564 0 0
Totale 26.060